Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach-Reference-Cited by-同舟云学术

Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach

Published:2022-11 Issue: Volume:173 Page:116-123
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Basse Clémence,Chabanol Hédi,Bonte Pierre-Emmanuel,Fromantin Isabelle,Girard Nicolas

Funder

Boehringer Ingelheim

Eli Lilly and Company

AstraZeneca

Amgen

AbbVie

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. IARC. Cancer Incidence, Mortality and Prevalence Worldwide GLOBOCAN 2012. http://gco.iarc.fr.

2. Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html. Accessed 30 Aug 2015.

3. Screening for germline EGFR T790M mutations through lung cancer genotyping;Oxnard;J Thorac Oncol,2012

4. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. World Health Organization International Agency for Research on Cancer. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=lung. Accessed on 07 Sep 2015.

5. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer (Version 7.2015). http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 30 June, 2015.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneath the surface: Novel insights into Amivantamab-induced acneiform rash;European Journal of Cancer;2024-09

2. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

3. Current status and breakthroughs in treating advanced non-small cell lung cancer with EGFR exon 20 insertion mutations;Frontiers in Immunology;2024-05-07

4. Severe scalp ulcerations and granulomata during treatment with amivantamab;Current Problems in Cancer: Case Reports;2024-03

5. The development of amivantamab for the treatment of non-small cell lung cancer;Respiratory Research;2023-10-25